Pandemic
Bio-Rad's blood-based immunoassay test can help clinicians identify if an individual has developed antibodies against SARS-CoV-2, the virus associated with COVID-19
| 1 min read
Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership
| 2 min read
Findings could explain why some COVID-19 patients experience gastrointestinal symptoms, and the fact that the virus often can be detected in stool samples
| 3 min read
The COVID-19 Research Pass program provides direct access to over 26 million articles and is available to anyone studying or writing about COVID-19
| 2 min read
New research used a data-driven modeling approach to answer the question of when the strict social distancing and quarantine measures against COVID-19 can be loosened
| 3 min read
Long-time provider of high-quality APIs ramps up supply to meet surging demand for products needed to manage respiratory critical care patients
| 2 min read
Researchers around the world are exploring how cannabis could treat or prevent COVID-19, but the results are too early to be definitive
| 4 min read
The new product line includes a real-time RT-PCR assay to screen for infected individuals and immunodiagnostic tests for IgM and IgG COVID-19 antibodies
| 2 min read
With manufacturing support from Omega Diagnostics, the laboratory-based test aims to deliver up to 46,000 results per day
| 2 min read
Until there are clinical trials that offer clear direction on a different treatment approach, state-of-the-art supportive care is the best option, medical experts say
| 2 min read
